Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (11-20 of 375) with videos related to

Pageof 38
Sort By:
Recenti Progressi in Medicina|November 17, 2024
Marta Perachino, Matteo Lambertini
Breast Cancer Research and Treatment|January 17, 2018
How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer?Matteo Lambertini, Caterina Fontanella
Recenti Progressi in Medicina|October 24, 2024
Marta Perachino, Matteo Lambertini
Cancer Prevention Research (Philadelphia, Pa.)|March 3, 2026
The Long and Winding Road toward Prevention of Estrogen Receptor-Negative and BRCA1-Associated Breast CancerAndrea DeCensi, Matteo Lambertini
European Radiology|October 16, 2024
Further insights into the use of contrast-enhanced imaging for breast cancer follow-up: the pros viewElisabetta Giannotti, Matteo Lambertini
The Lancet Regional Health. Europe|February 10, 2025
Dose-dense anthracycline- and taxane-based chemotherapy remains the preferred treatment for selected patients with high-risk early breast cancerMatteo Lambertini, Bo Nordenskjold
Expert Review of Endocrinology & Metabolism|April 23, 2026
New guidelines for premature ovarian insufficiency: a step forward or more hurdles?Arianna Daneri, Matteo Lambertini
The Lancet. Oncology|March 16, 2020
Is HER2-positive metastatic breast cancer still an incurable disease?Matteo Lambertini, Ines Vaz-Luis
The Oncologist|October 15, 2015
Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?Lucia Del Mastro, Matteo Lambertini
Journal of the National Cancer Institute|April 6, 2021
Cyclophosphamide-Free Adjuvant Chemotherapy for the Potential Prevention of Premature Ovarian Insufficiency and Infertility in Young Women With Breast CancerMatteo Lambertini, Ann H Partridge
Pageof 38

Showing results (11-20 of 375) with videos related to

Sort By:
Pageof 38
Recenti Progressi in Medicina|November 17, 2024
Marta Perachino, Matteo Lambertini
Breast Cancer Research and Treatment|January 17, 2018
How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer?Matteo Lambertini, Caterina Fontanella
Recenti Progressi in Medicina|October 24, 2024
Marta Perachino, Matteo Lambertini
Cancer Prevention Research (Philadelphia, Pa.)|March 3, 2026
The Long and Winding Road toward Prevention of Estrogen Receptor-Negative and BRCA1-Associated Breast CancerAndrea DeCensi, Matteo Lambertini
European Radiology|October 16, 2024
Further insights into the use of contrast-enhanced imaging for breast cancer follow-up: the pros viewElisabetta Giannotti, Matteo Lambertini
The Lancet Regional Health. Europe|February 10, 2025
Dose-dense anthracycline- and taxane-based chemotherapy remains the preferred treatment for selected patients with high-risk early breast cancerMatteo Lambertini, Bo Nordenskjold
Expert Review of Endocrinology & Metabolism|April 23, 2026
New guidelines for premature ovarian insufficiency: a step forward or more hurdles?Arianna Daneri, Matteo Lambertini
The Lancet. Oncology|March 16, 2020
Is HER2-positive metastatic breast cancer still an incurable disease?Matteo Lambertini, Ines Vaz-Luis
The Oncologist|October 15, 2015
Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?Lucia Del Mastro, Matteo Lambertini
Journal of the National Cancer Institute|April 6, 2021
Cyclophosphamide-Free Adjuvant Chemotherapy for the Potential Prevention of Premature Ovarian Insufficiency and Infertility in Young Women With Breast CancerMatteo Lambertini, Ann H Partridge
Pageof 38